TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25302460

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) using a GaAlAs laser (830 nm, 100 mW, illuminated area 0.028 cm2, 3.57 W/cm2, 20 sec, 2.0 J, 71 J/cm2), applied punctually in the major salivary glands, twice a week for 6 weeks (total of 12 sessions)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 23
Study: 22130398

Group type: EXPERIMENTAL
Intervention: Small-sided games (SSGs)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: High-intensity intermittent training (HIT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 22
Study: 20216293

Group type: EXPERIMENTAL
Intervention: Multispot 532-nm pattern scan laser (PASCAL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 532-nm solid-state green laser (GLX)
Number of subjects: 60
Study: 18166407

Group type: EXPERIMENTAL
Intervention: Dorzolamide/timolol fixed combination (DTFC) twice daily for 6 months
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Latanoprost every evening for 6 months
Number of subjects: 53

Group type: COMPARATOR
Intervention: Latanoprost
Number of subjects: 53

Group type: COMPARATOR
Intervention: Dorzolamide/timolol fixed combination (DTFC)
Number of subjects: 53
Study: 16202351

Group type: EXPERIMENTAL
Intervention: Reduction and fixation
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Bipolar hemiarthroplasty
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Total hip arthroplasty
Number of subjects: 298

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 298
Study: 12822347

Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation with Kirschner wire for radius-humeral joint (without ulna fixation)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Open reduction and internal fixation with Kirschner wire for both radius-humeral joint and ulna fracture
Number of subjects: 78
Study: 11167307

Group type: EXPERIMENTAL
Intervention: Oral creatine supplementation (20 g d(‐1) for 7 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 8872689

Group type: COMPARATOR
Intervention: succinylcholine 1.0 mg/kg
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Combination of rocuronium 0.6 mg/kg and mivacurium 0.15 mg/kg
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: rocuronium 0.6 mg/kg
Number of subjects: 70
Study: 1642441

Group type: EXPERIMENTAL
Intervention: Cibenzoline (390 mg/day in 3 divided doses)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Propafenone (900 mg/day in 3 divided doses)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cibenzoline
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 18
Study: 6472796

Group type: EXPERIMENTAL
Intervention: Solcoseryl Eye-Gel
Number of subjects: 99

Group type: COMPARATOR
Intervention: Cysteine Eye-Gel
Number of subjects: 99
Study: 30585373

Group type: EXPERIMENTAL
Intervention: Tryptophan loading (increased brain serotonin synthesis)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Tryptophan depletion (decreased brain serotonin synthesis)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control condition (no specific intervention mentioned)
Number of subjects: 85
Study: 29986174

Group type: EXPERIMENTAL
Intervention: Medicated patients with MDD
Number of subjects: 121

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 121
Study: 27383495

Group type: EXPERIMENTAL
Intervention: Linkus syrup
Number of subjects: 360

Group type: COMPARATOR
Intervention: Aminophylline with Diphenhydramine
Number of subjects: 360

Group type: COMPARATOR
Intervention: Acefyllin Piperazine with Diphenhydramine
Number of subjects: 360
Study: 24660156

Group type: EXPERIMENTAL
Intervention: Acetaminophen 15 mg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ibuprofen 10 mg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 22572984

Group type: EXPERIMENTAL
Intervention: Preseasonal immunotherapy with olive pollen allergoid
Number of subjects: 437
Study: 20818886

Group type: EXPERIMENTAL
Intervention: Nanofiltered C1 inhibitor concentrate (1000 units)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 18631168

Group type: EXPERIMENTAL
Intervention: CREG-matched PLT transfusions
Number of subjects: 73

Group type: COMPARATOR
Intervention: Crossmatch-selected PLT transfusions
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: TMM
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: EMM
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: CREG
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Crossmatching
Number of subjects: 73
Study: 15891330

Group type: EXPERIMENTAL
Intervention: Percutaneous translaryngeal tracheostomy (TLT)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Surgical tracheostomy (ST)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 139
Study: 12760854

Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 4047

Group type: COMPARATOR
Intervention: Comparator drugs
Number of subjects: 4047
Study: 10594475

Group type: EXPERIMENTAL
Intervention: Cisapride (10 mg three times daily for 4 consecutive days)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ethanol ingestion on an empty stomach
Number of subjects: 10

Group type: COMPARATOR
Intervention: No drug treatment (control)
Number of subjects: 10
Study: 7795940

Group type: EXPERIMENTAL
Intervention: Physical practice (one session)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Physical practice (two sessions)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Imaginary practice (one session)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Imaginary practice (two sessions)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination of physical practice and rest periods (two sessions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no interpolated activity)
Number of subjects: 60
Study: 1781537

Group type: EXPERIMENTAL
Intervention: Propofol preceded by 10 ml of 0.9% saline at 4 degrees C
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unmodified propofol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cold propofol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propofol with 0.05% lignocaine
Number of subjects: 0
Study: 7457708

Group type: EXPERIMENTAL
Intervention: Escharotomy
Number of subjects: 18

Group type: COMPARATOR
Intervention: No escharotomy (control group)
Number of subjects: 18
Study: 30838890

Group type: EXPERIMENTAL
Intervention: 12-h intravenous acetylcysteine regimen (200 mg/kg over 4 h, 50 mg/kg over 8 h)
Number of subjects: 38

Group type: COMPARATOR
Intervention: 20-h intravenous acetylcysteine regimen (200 mg/kg over 4 h, 100 mg/kg over 16 h)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: NACSTOP‐abbreviated group
Number of subjects: 38

Group type: COMPARATOR
Intervention: NACSTOP‐control group
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Acute liver injury (ALI) group
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Hepatotoxicity group
Number of subjects: 38
Study: 27718150

Group type: EXPERIMENTAL
Intervention: Daily 1000 IU vitamin D3
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Weekly 7000 IU vitamin D3
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Monthly 30,000 IU vitamin D3
Number of subjects: 64
Study: 25401417

Group type: COMPARATOR
Intervention: Liberal erythrocyte transfusion strategy (transfusion when hemoglobin <9 g/dl)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Restrictive erythrocyte transfusion strategy (transfusion when hemoglobin <7 g/dl)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Liberal erythrocyte transfusion strategy
Number of subjects: 198
Study: 23632054

Group type: EXPERIMENTAL
Intervention: Modified vastus medialis saphenous nerve block
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Perifemoral saphenous nerve block
Number of subjects: 20

Group type: COMPARATOR
Intervention: Below the knee field block
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Perifemoral vs Modified vastus medialis
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Perifemoral technique
Number of subjects: 20
Study: 21070090

Group type: EXPERIMENTAL
Intervention: Intratympanic gadolinium (Gd) perfusion through the eustachian tube
Number of subjects: 20
Study: 19249414

Group type: EXPERIMENTAL
Intervention: Bimonthly tailored nurse-delivered behavioral telephone intervention
Number of subjects: 588

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 588
Study: 18042573

Group type: EXPERIMENTAL
Intervention: Quality assurance questionnaire
Number of subjects: 836

Group type: COMPARATOR
Intervention: Standard process of obtaining informed consent
Number of subjects: 836
Study: 15114056

Group type: EXPERIMENTAL
Intervention: Interferon-alpha therapy
Number of subjects: 27
Study: 14649969

Group type: EXPERIMENTAL
Intervention: Ginger (500 mg orally three times daily for three days)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Vitamin B6 (10 mg orally three times daily for three days)
Number of subjects: 138
Study: 10220013

Group type: EXPERIMENTAL
Intervention: G to A polymorphism at position -1438 of the 5-HT2A receptor gene
Number of subjects: 225

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 225
Study: 7604917

Group type: EXPERIMENTAL
Intervention: Sun safety curriculum administered to preschoolers
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 12
Study: 1369707

Group type: EXPERIMENTAL
Intervention: Nicardipine treatment
Number of subjects: 2184
Study: 377896

Group type: EXPERIMENTAL
Intervention: PGE2-gel (0.25 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: PGE2-gel (0.25 mg) with nifedipine
Number of subjects: 22
Study: 31790379

Group type: EXPERIMENTAL
Intervention: Maternal genetic variants as instruments for vitamin D
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulations assessing proposed instruments jointly
Number of subjects: 0
Study: 30472722

Group type: EXPERIMENTAL
Intervention: Incisional negative-pressure wound therapy (iNPWT)
Number of subjects: 0
Study: 28052111

Group type: EXPERIMENTAL
Intervention: doxylamine/pyridoxine/dicylcomine
Number of subjects: 2308

Group type: EXPERIMENTAL
Intervention: doxylamine/pyridoxine
Number of subjects: 2308

Group type: EXPERIMENTAL
Intervention: dicylomine/pyridoxine
Number of subjects: 2308

Group type: EXPERIMENTAL
Intervention: doxylamine
Number of subjects: 2308

Group type: EXPERIMENTAL
Intervention: dicyclomine/pyridoxine
Number of subjects: 2308

Group type: EXPERIMENTAL
Intervention: pyridoxine
Number of subjects: 2308

Group type: EXPERIMENTAL
Intervention: dicyclomine
Number of subjects: 2308

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2308
Study: 26297314

Group type: EXPERIMENTAL
Intervention: Community-based facilitation intervention (NeoKIP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Facilitators and participants' engagement
Number of subjects: 0
Study: 23695519

Group type: EXPERIMENTAL
Intervention: Daily SMS surveys for 60 days
Number of subjects: 96
Study: 21266143

Group type: EXPERIMENTAL
Intervention: Mindfulness program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting-list group (Control)
Number of subjects: 0
Study: 19884997

Group type: EXPERIMENTAL
Intervention: Continuous Interscalene Block (CISB)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Single Interscalene Block combined with Continuous Intra-bursal Infusion of Ropivacaine (ISB-IB)
Number of subjects: 50
Study: 17353401

Group type: EXPERIMENTAL
Intervention: Ruboxistaurin (RBX) 32 mg/day
Number of subjects: 686

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 686
Study: 15114199

Group type: EXPERIMENTAL
Intervention: Salbutamol (3 x 2 puffs, 0.2 mg)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Salbutamol combined with methylprednisolone (40 mg/day orally)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Salbutamol (2 puffs 10 min before anesthesia)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Salbutamol combined with methylprednisolone
Number of subjects: 31
Study: 11475710

Group type: EXPERIMENTAL
Intervention: Philips/Jordan 2‐Action Plaque Remover electric toothbrush
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral‐B 35 Advantage manual toothbrush
Number of subjects: 0
Study: 9737124

Group type: EXPERIMENTAL
Intervention: Ramipril (1.25 mg/d, n = 16)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (n = 12)
Number of subjects: 28
Study: 30652317

Group type: EXPERIMENTAL
Intervention: Intervention group (IG) - skin care programme with cream dispensers and electronic monitoring.
Number of subjects: 501

Group type: COMPARATOR
Intervention: Control group (CG) - standard care without the intervention.
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Intervention group (IG) - subgroup of HCWs with mild HD.
Number of subjects: 501
Study: 28410857

Group type: EXPERIMENTAL
Intervention: Problem Solving Therapy (PST) - 6-8 sessions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 26088658

Group type: EXPERIMENTAL
Intervention: Therapeutic Horseback Riding (THR)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Barn Activity (BA) Control
Number of subjects: 127
Study: 23601071

Group type: EXPERIMENTAL
Intervention: 50 mg/day vitamin E and 150 mg/day vitamin C
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 19445435

Group type: EXPERIMENTAL
Intervention: Low-fat, high-fruit/vegetable dietary intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed control ROs
Number of subjects: 0
Study: 19263531

Group type: EXPERIMENTAL
Intervention: Modified wheelchair with ESP mechanism
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard dual handrim wheelchair
Number of subjects: 10
Study: 14998946

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.25 mg daily
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 12207146

Group type: EXPERIMENTAL
Intervention: Cortisol (hydrocortisone) 20 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cortisol (hydrocortisone) 40 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 9619929

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite-augmented porous coating
Number of subjects: 116

Group type: COMPARATOR
Intervention: Porous coating
Number of subjects: 116

Group type: COMPARATOR
Intervention: Cemented fixation
Number of subjects: 116
Study: 7639169

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fludrocortisone acetate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2515254

Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 619839

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Normobaric oxygen
Number of subjects: 82

Group type: COMPARATOR
Intervention: Hyperbaric air
Number of subjects: 82

Group type: COMPARATOR
Intervention: Normobaric air
Number of subjects: 82
Study: 30758702

Group type: EXPERIMENTAL
Intervention: Dabigatran 150 mg twice daily
Number of subjects: 635

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 635
Study: 28257071

Group type: EXPERIMENTAL
Intervention: ASSIP (Attempted Suicide Short Intervention Program)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 25514823

Group type: EXPERIMENTAL
Intervention: Nd:YAG 1320-nm laser mini-peel
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Er:YAG 2940-nm laser mini-peel
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: ELOS
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intense Pulsed Light (IPL)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Mesotherapy injection
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (30 subjects)
Number of subjects: 36
Study: 23343596

Group type: EXPERIMENTAL
Intervention: d-amphetamine (AMPH) 5 mg
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: d-amphetamine (AMPH) 10 mg
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: d-amphetamine (AMPH) 20 mg
Number of subjects: 286

Group type: COMPARATOR
Intervention: d-amphetamine (AMPH) 0 mg (placebo)
Number of subjects: 286
Study: 21112044

Group type: EXPERIMENTAL
Intervention: Pilocarpine (5mg)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Tramadol (50mg 3×/day over two days)
Number of subjects: 65
Study: 19672133

Group type: EXPERIMENTAL
Intervention: Adherence therapy (during the 12 months after enrollment)
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Medication Adherence Rating Scale (MARS)
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Compliance Rating Scale (CRS)
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Psychopathology
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Unemployment and poor subjective tolerability of antipsychotics
Number of subjects: 409
Study: 17088333

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (Dysport) injection (500 Speywood units)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 20
Study: 15213032

Group type: EXPERIMENTAL
Intervention: High food reinforcement with no SLC6A3*9 allele
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: High food reinforcement with at least one DRD(2)*A1 allele
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: High food reinforcement
Number of subjects: 88
Study: 11591194

Group type: EXPERIMENTAL
Intervention: Repeated low-dose allergen exposure (1/5 of the provocative dose)
Number of subjects: 12
Study: 9498445

Group type: EXPERIMENTAL
Intervention: Active product (milk-derived immunoglobulin)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Lactose-free placebo
Number of subjects: 25
Study: 7913549

Group type: EXPERIMENTAL
Intervention: Salmeterol 50 micrograms twice daily for 4 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2655907

Group type: EXPERIMENTAL
Intervention: Fenofibrate 100 mg three times daily for eight weeks
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Fenofibrate 100 mg three times daily for eight weeks (Group B)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study: 30845794

Group type: EXPERIMENTAL
Intervention: Breathing exercise intervention (13.1±3.7 minutes per day for the first two months, 11.1±3.9 minutes per day for the next two months)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 37
Study: 28317684

Group type: EXPERIMENTAL
Intervention: OVD 1 (Twinvisc)
Number of subjects: 220

Group type: COMPARATOR
Intervention: OVD 2 (Duovisc)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Both OVDs
Number of subjects: 220
Study: 26282643

Group type: EXPERIMENTAL
Intervention: Aspirin 600 mg per day
Number of subjects: 937

Group type: COMPARATOR
Intervention: Aspirin placebo
Number of subjects: 937

Group type: EXPERIMENTAL
Intervention: Resistant starch 30 g per day
Number of subjects: 937

Group type: COMPARATOR
Intervention: Starch placebo
Number of subjects: 937
Study: 24669558

Group type: EXPERIMENTAL
Intervention: HoLEP
Number of subjects: 40

Group type: COMPARATOR
Intervention: TURP
Number of subjects: 40
Study: 21168000

Group type: EXPERIMENTAL
Intervention: High-dose tirofiban (HDT)
Number of subjects: 1121

Group type: COMPARATOR
Intervention: Control (placebo or no HDT)
Number of subjects: 1121
Study: 19057524

Group type: EXPERIMENTAL
Intervention: High-glycemic index (HGI) diet, n = 19
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Low-glycemic index (LGI) diet, n = 23
Number of subjects: 42
Study: 18260977

Group type: COMPARATOR
Intervention: sotalol 80 ‐ 160 mg/day
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: sotalol 80 ‐ 160 mg/day + perindopril 4 ‐ 8 mg/day
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: sotalol 80 ‐ 160 mg/day + rosuvastatin 5 ‐ 20 mg/day
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: sotalol 80 ‐ 160 mg/day + omega‐3 polyunsaturated fatty acids 1 g/day
Number of subjects: 187
Study: 14712346

Group type: EXPERIMENTAL
Intervention: Ringers lactate (RL)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Normal saline solution (NS)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: HES 130/0.4
Number of subjects: 66
Study: 12394551

Group type: EXPERIMENTAL
Intervention: Orbscan Topography System (version 3.0)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Ultrasonic pachymeter (Ophthasonic A-Scan/Pachometer III)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Comparison of both methods
Number of subjects: 92
Study: 9748099

Group type: EXPERIMENTAL
Intervention: Protein-rich meal
Number of subjects: 42

Group type: COMPARATOR
Intervention: Protein-poor meal
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Glucide content between 125 and 150 g
Number of subjects: 42

Group type: COMPARATOR
Intervention: Glucide content more than 150 g
Number of subjects: 42
Study: 8135385

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 202

Group type: COMPARATOR
Intervention: Epidural anesthesia
Number of subjects: 202
Study: 2718822

Group type: EXPERIMENTAL
Intervention: Solid meal
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Liquid meal
Number of subjects: 12

Group type: COMPARATOR
Intervention: No meal
Number of subjects: 12
Study: 791587

Group type: EXPERIMENTAL
Intervention: Piperazine oestrone sulphate ('Harmogen')
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 30358219

Group type: EXPERIMENTAL
Intervention: Cetuximab combined with radical radiotherapy
Number of subjects: 62

Group type: COMPARATOR
Intervention: Radical radiotherapy
Number of subjects: 62
Study: 26315980

Group type: EXPERIMENTAL
Intervention: Second-generation antipsychotic treatment
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Striatal connectivity index
Number of subjects: 81
Study: 25204190

Group type: EXPERIMENTAL
Intervention: Qishen Yiqi dropping pills (0.5 g each time, three times a day for seven days)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine heart and diuretic treatments and placebo of Qishen Yiqi dropping pills (0.5 g each time, three times a day for seven days)
Number of subjects: 120